Results 381 to 390 of about 1,467,646 (404)
Some of the next articles are maybe not open access.

Functional patient-derived organoid screenings identify MCLA-158 as a therapeutic EGFR × LGR5 bispecific antibody with efficacy in epithelial tumors

Nature Cancer, 2022
B. Herpers   +38 more
semanticscholar   +1 more source

Safety and efficacy of mosunetuzumab, a bispecific antibody, in patients with relapsed or refractory follicular lymphoma: a single-arm, multicentre, phase 2 study.

The Lancet Oncology, 2022
L. Budde   +19 more
semanticscholar   +1 more source

Bispecific antibodies rise again

Nature Reviews Drug Discovery, 2014
Amgen's blinatumomab is setting the stage for a bispecific revival, enabled by new formats that may solve the field's long-standing problems.
openaire   +3 more sources

Treatment of muscle‐invasive and advanced bladder cancer in 2020

Ca-A Cancer Journal for Clinicians, 2020
Vaibhav G Patel   +2 more
exaly  

Avidity in antibody effector functions and biotherapeutic drug design

Nature Reviews Drug Discovery, 2022
Simone C Oostindie   +2 more
exaly  

Bispecific Monoclonal Antibodies [PDF]

open access: possibleClinical Lymphoma Myeloma and Leukemia, 2015
openaire   +1 more source

Hodgkin lymphoma: A review and update on recent progress

Ca-A Cancer Journal for Clinicians, 2018
Satish Shanbhag, Richard F Ambinder
exaly  

COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses

Nature, 2020
Alexander Muik   +2 more
exaly  

Understanding biology to tackle the disease: Multiple myeloma from bench to bedside, and back

Ca-A Cancer Journal for Clinicians, 2014
Giada Bianchi, Federico Gago
exaly  

Home - About - Disclaimer - Privacy